Genetic Signatures Limited (ASX:GSS)
Australia · Delayed Price · Currency is AUD 0.0790
0.00 (0.00%)
Oct 7, 2026, 3:58 PM AEST
Genetic Signatures Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 19.33 | 19.33 | 19.75 | 13.77 | 21.51 | 35.5 |
Revenue Growth | -3.03% | -2.14% | 43.47% | -36.00% | -39.39% | 25.06% |
Gross Profit Gross Profit Growth | 8.61 | 8.61 | 10.51 | 5.86 | 9.68 | 21.9 |
Operating Income Operating Income Growth | -12.86 | -12.86 | -14.63 | -18.33 | -14.59 | 3.03 |
Net Income Net Income Growth | -14.01 | -14.01 | -20.1 | -17.86 | -14.05 | 3.06 |
Earnings Per Share EPS Growth | -0.06 | -0.06 | -0.09 | -0.11 | -0.10 | 0.02 |
EPS Growth | - | - | - | - | - | 74.39% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EMEA EMEA Growth | 1.79 | 1.79 | 2.91 | 1.11 | 1.62 | 4.19 |
Americas Americas Growth | 0.43 | 0.43 | 0.3 | 0.03 | 0.39 | 0.14 |
Asia Pacific Asia Pacific Growth | 18.37 | 18.37 | 19.08 | 9.01 | 16.23 | 34.8 |
Total Total Growth | 20.6 | 20.6 | 22.3 | 13.77 | 21.51 | 35.42 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 22.1 | 22.1 | 31.3 | 36.25 | 16.35 | 36.9 |
Total Debt Total Debt Growth | 0.31 | 0.31 | 0.79 | 1.22 | - | 0.03 |
Net Cash (Debt) Net Cash Growth | 21.79 | 21.79 | 30.5 | 35.03 | 16.35 | 36.86 |
Net Cash Growth | -25.68% | -28.58% | -12.92% | 114.27% | -55.65% | 24.03% |
Net Cash Per Share Net Cash Per Share Growth | 0.10 | 0.10 | 0.13 | 0.21 | 0.11 | 0.25 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -7.77 | -7.77 | -12.29 | -10.12 | -12.45 | 9.81 |
Capital Expenditures CapEx Growth | -1.05 | -1.05 | -0.65 | -1.98 | -1.93 | -1.71 |
Free Cash Flow Free Cash Flow Growth | -8.82 | -8.82 | -12.94 | -12.1 | -14.38 | 8.09 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 44.53% | 44.53% | 53.19% | 42.53% | 45.01% | 61.69% |
Operating Margin | -66.55% | -66.55% | -74.06% | -133.14% | -67.83% | 8.54% |
Pretax Margin | -72.45% | -72.45% | -101.78% | -129.74% | -65.32% | 8.63% |
Profit Margin | -72.45% | -72.45% | -101.78% | -129.74% | -65.32% | 8.63% |
FCF Margin | -45.62% | -45.62% | -65.52% | -87.88% | -66.86% | 22.80% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 7, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | - | - | - | - | - | 54.30 |
Forward PE | - | 85.15 | 85.15 | 85.15 | 85.15 | 85.15 |
P/FCF Ratio | - | - | - | - | - | 20.56 |
PS Ratio | 0.93 | 0.79 | 4.20 | 11.26 | 3.50 | 4.69 |